ROHTO PHARMACEUTICAL（4527）

News ReleaseMore

Aug. 26, 2024
JCR Affirmed A+/Stable Long-term Issuer Rating on ROHTO PHARMACEUTICAL
Apr. 05, 2024
ROHTO PHARMACEUTICAL Announced Acquisition of a Singaporean Health and Wellness Manufacturing and Sales Company - Limited Impact on Rating
May. 24, 2023
JCR Affirmed A+/Stable Long-term Issuer Rating on ROHTO PHARMACEUTICAL
May. 25, 2022
JCR Affirmed A+/Stable Long-term Issuer Rating on ROHTO PHARMACEUTICAL
May. 26, 2021
JCR Affirmed A+/Stable Long-term Issuer Rating on ROHTO PHARMACEUTICALMember Only
Jun. 29, 2020
JCR Upgraded Rating on ROHTO PHARMACEUTICAL from A/Positive to A+/StableMember Only
Jun. 04, 2019
JCR Affirmed A Rating on ROHTO PHARMACEUTICAL; Revised Outlook from Stable to PositiveMember Only
Jun. 11, 2018
JCR Affirmed A/Stable Long-term Issuer Rating on ROHTO PHARMACEUTICALMember Only
Jun. 07, 2017
JCR Affirmed A/Stable on ROHTO PHARMACEUTICALMember Only
Jun. 13, 2016
JCR Affirmed A/Stable on ROHTO PHARMACEUTICALMember Only

Issuer ReportsMore

ESG Credit OutlookMore

Reports relating to IssuerMore

Rating Lists
Corporates
Financial Institutions
Public Sector
Structured Finance (Investment Corporations)
Structured Finance (Structured Finance Products)
Sovereigns and Supranationals